JP Morgan Chase
PEAR

JP Morgan Chase’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

JP Morgan Chase’s Portfolio PEAR Stock Details PEAR Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
2023
Q1 		$14K Buy
2022
Q4 		$46K Buy
2022
Q3 		$76K Sell
2022
Q2 		$142K Buy
2022
Q1 		$7K Buy
2021
Q4 		– Sell
2021
Q3 		$923K Buy